Why the study?
Myocardial ischemia/reperfusion injury has a high disability rate and mortality, creating a need for novel treatments.
Does hydromorphine postconditioning protect isolated rat hearts against ischemia-reperfusion injury?
Does hydromorphine postconditioning protect isolated rat hearts against ischemia-reperfusion injury?
Hydromorphine postconditioning protects against myocardial ischemia-reperfusion injury in isolated rat hearts via activation of the PI3K/Akt/eNOS signaling pathway.
Hydromorphine may attenuate experimental myocardial I/R injury; leaves open clinical translation and safety.
INTRODUCTION: Myocardial ischemia/reperfusion injury (myocardial I/R injury) has a high disability rate and mortality. Novel treatments for myocardial I/R injury are necessary. AIM: In order to explore the protective effect of hydromorphine on myocardial I/R injury, we illuminate the underlying mechanism of the protective effect. RESULTS: Hydromorphine significantly reduced myocardial infarct size (IFN/AAR), CKMB (Creatine Kinase MB) and TN-T (Troponin T) release, and improved cardiac function compared with I/R group. However, these advantageous effects were partly suppressed in the presence of hydromorphine. Myocardial I/R injury significantly decreased the phosphorylation of Akt and eNOS, and down-regulated total nitric oxide and nitrotyrosine content, while these inhibitory effects were partly abolished by hydromorphine. Conversely, the activated effects of hydromorphine on the phosphorylation of Akt and eNOS, and NO release were totally reversed by LY294002, which, used individually, show the same influence on reperfusion injury. CONCLUSIONS: These findings suggest that hydromorphine postconditioning may protect isolated rat heart against reperfusion injury via activating P13K/Akt/eNOS signaling.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: